1-10 of 10
perceptual masking
Close
Sort by
Journal Articles

A Short N-Terminal Fragment in Front of the A1 Domain of Von Willebrand Factor Prevents the A1 from Binding the Platelet By Masking a Region Clustered By Type 2B VWD Mutations

Wei Deng, PhD, Yingchun Wang, PhD, Pete Lollar, MD, Renhao Li, PhD
Journal: Blood
Blood (2016) 128 (22): 553.
https://doi.org/10.1182/blood.V128.22.553.553
Published: 2016
Journal Articles

Superimposed Hypercoagulable and Hypocoagulable States: Elevated Von Willebrand Factor (vWF) Levels Secondary to Polycystic Ovary Syndrome Masking Von Willebrand Disease

Kristen M Scheitler, Post-Sophomore Fellow, Emily A Coberly, MD, A. Mosharraf Hossain, MD, Richard D Hammer, MD
Journal: Blood
Blood (2016) 128 (22): 4989.
https://doi.org/10.1182/blood.V128.22.4989.4989
Published: 2016
Journal Articles

Rare Case of Alternative Splicing Form Caused By L248V Mutation in CML Patient

Pavel Butylin, PhD, Natalia Matyuhina, MS, Nadia Siordia, MD, Elza Lomaya, MD, Andrey Zaritskey, MD
Journal: Blood
Blood (2015) 126 (23): 5139.
https://doi.org/10.1182/blood.V126.23.5139.5139
Published: 2015
Journal Articles

Defining The morphological Appearance Of ETV6-Abl Diseases. Evaluation Of a Case

Finella MC Brito-Babapulle, FRCPATH, Barbara Czepulkowski, BSc
Journal: Blood
Blood (2013) 122 (21): 5271.
https://doi.org/10.1182/blood.V122.21.5271.5271
Published: 2013
Journal Articles

Modulating the Factor V Procofactor to Cofactor Transition Using Recombinant B-Domain Fragments

Matthew W Bunce, PhD, Mettine H.A. Bos, PhD, Rodney M. Camire, PhD
Journal: Blood
Blood (2011) 118 (21): 376.
https://doi.org/10.1182/blood.V118.21.376.376
Published: 2011
Journal Articles

Insights into the regulatory mechanism controlling the inhibition of vaccine-induced seroconversion by maternal antibodies

Dhohyung Kim, Devra Huey, Michael Oglesbee, Stefan Niewiesk
Journal: Blood
Blood (2011) 117 (23): 6143–6151.
https://doi.org/10.1182/blood-2010-11-320317
Published: 2011
Journal Articles

Masked Hypodiploidy: Hypodiploid Acute Lymphoblastic Leukemia (ALL) in Children Mimicking Hyperdiploid ALL: A Report From the Children's Oncology Group (COG) AALL03B1 Study.

Andrew J. Carroll, PhD, Nyla A. Heerema, PhD, Julie M. Gastier-Foster, PhD, Caroline Astbury, PhD, Robert Pyatt, PhD, Shalini C. Reshmi, PhD, Michael J. Borowitz, MD, PhD, Meenakshi Devidas, PhD, Stephen Linda, MS, Mignon L. Loh, MD, Elizabeth A. Raetz, MD, Brent Wood, MD, PhD, Naomi J. Winick, MD, Stephen P. Hunger, MD, William L. Carroll, MD
Journal: Blood
Blood (2009) 114 (22): 1580.
https://doi.org/10.1182/blood.V114.22.1580.1580
Published: 2009
Journal Articles

Peroxiredoxin-2 (Prx2) Membrane Displacement is A New Additional Factor to the Severity of β-Thalassemic Mouse Red Cell Membrane Damage.

Alessandro Mattè, Philip S. Low, PhD, Franco Turrini, Mariarita Bertoldi, Maria Estela Campanella, Antonella Pantaleo, Angela Siciliano, Lucia De Franceschi, MD
Journal: Blood
Blood (2009) 114 (22): 2009.
https://doi.org/10.1182/blood.V114.22.2009.2009
Published: 2009
Journal Articles

NOTCH1 Is Targeted by Ig Translocations in NHL.

Iwona Wlodarska, PhD, Chris De Wolf-Peeters, MD, PhD, Jan Cools, PhD, Francesca Minnei, MD, Andre Bosly, MD, PhD, Monique Delos, MD, Lucienne Michaux, MD, PhD, Peter Vandenberghe, MD, PhD, Anne Hagemeijer, MD, PhD, Peter Marynen, PhD
Journal: Blood
Blood (2005) 106 (11): 4339.
https://doi.org/10.1182/blood.V106.11.4339.4339
Published: 2005
Journal Articles

A Pilot Study of Thrice-Weekly Low Dose Rituximab (RTX) in the Treatment of Chronic Lymphocytic Leukemia (CLL) Suggests Enhanced Therapeutic Targeting Compared to Standard Dose Regimens.

Ronald P. Taylor, Ph.D., Andrew W. Pawluczkowycz, M.S., Paul V. Beum, Ph.D., Adam D. Kennedy, M.S., Margaret A. Lindorfer, Ph.D., John J. Densmore, M.D., Ph.D., Jane Eggleton, R.N., Karen L. LoRusso, M.D., Michael E. Williams, M.D.
Journal: Blood
Blood (2004) 104 (11): 2520.
https://doi.org/10.1182/blood.V104.11.2520.2520
Published: 2004